Laura Towart, Founder and CEO at Vivan Therapeutics, member of 100 Influential Women in Oncology, shared a post on LinkedIn:
“Vivan Therapeutics has expanded to Asia!
We made our first hire in China, Vivienne Liwei, in the role of Clinical Engagement Lead. We are pleased to welcome Vivienne to our growing commercial team. Our China expansion has been supported by the P4 Precision Medicine Accelerator, P4 Beijing, including guidance from Nathan McNally, Lynn Huang, Rainie Xiaoyu Chen, Ross Cagan, Kristina GTIP, Peter Tensen, and Zhihao (James) Feng (UK Embassy Beijing).
Please contact us to find out how we can identify personalized, effective combination therapies for your cancer. We are also able to coordinate specialized cancer treatment and/or second opinions in the USA, UAE, UK, Switzerland or Singapore. Contact us to learn more.”
More posts featuring Laura Towart.